FASEB J. Uncover Your Biological Pathway
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.07-8636com.
(The FASEB Journal. 2008;22:930-940.)
© 2008 FASEB
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.07-8636comv1
22/3/930    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fazel, S. S.
Right arrow Articles by Li, R.-K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fazel, S. S.
Right arrow Articles by Li, R.-K.
(The FASEB Journal. 2008;22:930-940.)
© 2008 FASEB

Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury

Shafie S. Fazel*, Liwen Chen*, Denis Angoulvant*, Shu-Hong Li*, Richard D. Weisel*, Armand Keating{dagger} and Ren-Ke Li*,1

* Division of Cardiac Surgery, Department of Surgery, Toronto General Hospital Research Institute, and

{dagger} Department of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada

1Correspondence: Toronto General Hospital, MaRS Centre, Toronto Medical Discovery Tower, Rm. 3–702, 101 College St., Toronto, ON, Canada, M5G 1L7, E-mail: renkeli{at}uhnres.utoronto.ca

Cardiovascular disease is the number-one cause of mortality in the developed world. The aim of this study is to define the mechanisms by which bone marrow progenitor cells are mobilized in response to cardiac ischemic injury. We used a closed-chest model of murine cardiac infarction/reperfusion, which segregated the surgical thoracotomy from the induction of cardiac infarction, so that we could study isolated fluctuations in cytokines without the confounding impact of surgery. We show here that bone marrow activation of the c-kit tyrosine kinase receptor in response to released soluble KitL is necessary for bone marrow progenitor cell mobilization after ischemic cardiac injury. We also show that release of KitL and c-kit activation require the activity of matrix metalloproteinase-9 within the bone marrow compartment. Finally, we demonstrate that mice with c-kit dysfunction develop cardiac failure after myocardial infarction and that bone marrow transplantation rescues the failing cardiac phenotype. In light of the ongoing trials of progenitor cell therapy for heart disease, our study outlines the endogenous repair mechanisms that are invoked after cardiac injury. Amplification of this pathway may aid in restoration of cardiac function after myocardial infarction.—Fazel, S. S., Chen, L., Angoulvant, D., Li, S. H., Weisel, R. D., Keating, A., Li, R. K. Activation of c-kit is necessary for mobilization of reparative bone marrow progenitor cells in response to cardiac injury.


Key Words: myocardial infarction • heart failure • stem cells • cell signaling




This article has been cited by other articles:


Home page
Circ. Res.Home page
K. C. Young, E. Torres, K. E. Hatzistergos, D. Hehre, C. Suguihara, and J. M. Hare
Inhibition of the SDF-1/CXCR4 Axis Attenuates Neonatal Hypoxia-Induced Pulmonary Hypertension
Circ. Res., June 5, 2009; 104(11): 1293 - 1301.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Sun, S.-H. Li, S.-M. Liu, J. Wu, R. D. Weisel, Y.-F. Zhuo, T. M. Yau, R.-K. Li, and S. S. Fazel
Improvement in cardiac function after bone marrow cell thearpy is associated with an increase in myocardial inflammation
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H43 - H50.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.